SNRPD1 and breast carcinoma: Our results differentiated SNRPD1 from SNRPE at both prognostic and therapeutic levels and preliminarily explained the potential driving mechanisms, with the aim of advancing our therapeutic control of breast cancers via targeting these two genes.